These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16611060)

  • 1. Factors influencing adherence to highly active antiretroviral therapy in Spain.
    Moralejo L; Inés S; Marcos M; Fuertes A; Luna G
    Curr HIV Res; 2006 Apr; 4(2):221-7. PubMed ID: 16611060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to highly active antiretroviral therapy in HIV-infected inmates.
    Inés SM; Moralejo L; Marcos M; Fuertes A; Luna G
    Curr HIV Res; 2008 Mar; 6(2):164-70. PubMed ID: 18336264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy.
    Gordillo V; del Amo J; Soriano V; González-Lahoz J
    AIDS; 1999 Sep; 13(13):1763-9. PubMed ID: 10509579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach.
    Spire B; Duran S; Souville M; Leport C; Raffi F; Moatti JP;
    Soc Sci Med; 2002 May; 54(10):1481-96. PubMed ID: 12061483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Field adherence to highly active antiretroviral therapy in HIV-infected adults in Abidjan, Côte d'Ivoire.
    Eholié SP; Tanon A; Polneau S; Ouiminga M; Djadji A; Kangah-Koffi C; Diakité N; Anglaret X; Kakou A; Bissagnené E
    J Acquir Immune Defic Syndr; 2007 Jul; 45(3):355-8. PubMed ID: 17438479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphologic alterations in HIV-infected people with lipodystrophy are associated with good adherence to HAART.
    Guaraldi G; Murri R; Orlando G; Orlandi E; Sterrantino G; Borderi M; Grosso C; Cattelan AM; Nardini G; Beghetto B; Antinori A; Esposito R; Wu AW
    HIV Clin Trials; 2003; 4(2):99-106. PubMed ID: 12671777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent use of comedications reduces adherence to antiretroviral therapy among HIV-infected patients.
    Cantudo-Cuenca MR; Jiménez-Galán R; Almeida-Gonzalez CV; Morillo-Verdugo R
    J Manag Care Spec Pharm; 2014 Aug; 20(8):844-50. PubMed ID: 25062078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simpler regimens may enhance adherence to antiretrovirals in HIV-infected patients.
    Maggiolo F; Ripamonti D; Arici C; Gregis G; Quinzan G; Camacho GA; Ravasio L; Suter F
    HIV Clin Trials; 2002; 3(5):371-8. PubMed ID: 12407486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-adherence to highly active antiretroviral therapy in children attending HIV treatment clinic at harare Children's Hospital, Zimbabwe.
    Chimhuya S; Nathoo KJ; Rusakaniko S
    Cent Afr J Med; 2013; 59(9-12):63-70. PubMed ID: 29144622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to antiretroviral therapy in children attending Mulago Hospital, Kampala.
    Nabukeera-Barungi N; Kalyesubula I; Kekitiinwa A; Byakika-Tusiime J; Musoke P
    Ann Trop Paediatr; 2007 Jun; 27(2):123-31. PubMed ID: 17565809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Factors predicting lack of adherence to highly active antiretroviral treatment].
    Martín-Sánchez V; Ortega-Valín L; Pérez-Simón Mdel R; Mostaza-Fernández JL; Ortiz de Urbina-González JJ; Rodríguez-María M; Carro-Fernández JA; Cuevas-González MJ; Alcoba-Leza M;
    Enferm Infecc Microbiol Clin; 2002 Dec; 20(10):491-7. PubMed ID: 12433350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mean levels of adherence and factors contributing to non-adherence in patients on highly active antiretroviral therapy.
    Williams M; Clarke T; Williams P; Barton EN
    West Indian Med J; 2007 Jun; 56(3):270-4. PubMed ID: 18072411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing limiting factors to the acceptance of antiretroviral therapy in a large cohort of injecting drug users.
    Clarke S; Delamere S; McCullough L; Hopkins S; Bergin C; Mulcahy F
    HIV Med; 2003 Jan; 4(1):33-7. PubMed ID: 12534957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of demographic and psychosocial factors on adherence to antiretroviral treatment].
    Ruiz-Pérez I; Olry de Labry-Lima A; Prada-Pardal JL; Rodríguez-Baño J; Causse-Prados M; López-Ruz MA; Martín-Rico P; del Arco-Jiménez A; Pasquau-Liaño J; de la Torre-Lima J; López-Gómez M; Muñoz-Roca N; Marcos-Herrero M; Muñoz I; Morales-Rojas D
    Enferm Infecc Microbiol Clin; 2006; 24(6):373-8. PubMed ID: 16792939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of short-term success of antiretroviral therapy in HIV infection.
    Oette M; Kroidl A; Göbels K; Stabbert A; Menge M; Sagir A; Kuschak D; O'hanley T; Bode JG; Häussinger D
    J Antimicrob Chemother; 2006 Jul; 58(1):147-53. PubMed ID: 16687458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens.
    Horberg M; Silverberg M; Hurley L; Delorenze G; Quesenberry C
    AIDS Patient Care STDS; 2008 Apr; 22(4):301-12. PubMed ID: 18338961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intention to adhere to HIV treatment: a patient-centred predictor of antiretroviral adherence.
    Nelsen A; Gupta S; Trautner BW; Petersen NJ; Garza A; Giordano TP; Naik AD; Rodriguez-Barradas MC
    HIV Med; 2013 Sep; 14(8):472-80. PubMed ID: 23551395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
    Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease.
    Eldred LJ; Wu AW; Chaisson RE; Moore RD
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):117-25. PubMed ID: 9637576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.